BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 14728813)

  • 1. Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
    Sun TS; Guan K; Shi SS; Zhu B; Zheng YJ; Cui FZ; Zhang W; Liao SS
    Chin J Traumatol; 2004 Feb; 7(1):18-24. PubMed ID: 14728813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lumbar spinal fusion with a mineralized collagen matrix and rhBMP-2 in a rabbit model.
    Liao SS; Guan K; Cui FZ; Shi SS; Sun TS
    Spine (Phila Pa 1976); 2003 Sep; 28(17):1954-60. PubMed ID: 12973141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of carriers of bone morphogenetic protein for spinal fusion.
    Minamide A; Kawakami M; Hashizume H; Sakata R; Tamaki T
    Spine (Phila Pa 1976); 2001 Apr; 26(8):933-9. PubMed ID: 11317116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
    Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterolateral spinal fusion with nano-hydroxyapatite-collagen/PLA composite and autologous adipose-derived mesenchymal stem cells in a rabbit model.
    Tang ZB; Cao JK; Wen N; Wang HB; Zhang ZW; Liu ZQ; Zhou J; Duan CM; Cui FZ; Wang CY
    J Tissue Eng Regen Med; 2012 Apr; 6(4):325-36. PubMed ID: 21751422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis.
    Singh K; Dumonski M; Stanley T; Ponnappan R; Phillips FM
    Spine (Phila Pa 1976); 2011 Feb; 36(3):192-6. PubMed ID: 20634780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyapatite granule graft combined with recombinant human bone morphogenic protein-2 for solid lumbar fusion.
    Konishi S; Nakamura H; Seki M; Nagayama R; Yamano Y
    J Spinal Disord Tech; 2002 Jun; 15(3):237-44. PubMed ID: 12131427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
    Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
    Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental spinal fusion with recombinant human bone morphogenetic protein-2.
    Schimandle JH; Boden SD; Hutton WC
    Spine (Phila Pa 1976); 1995 Jun; 20(12):1326-37. PubMed ID: 7676329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
    Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of coralline hydroxyapatite with bone marrow, autogenous bone graft, or osteoinductive bone protein extract for posterolateral lumbar spine fusion.
    Boden SD; Martin GJ; Morone M; Ugbo JL; Titus L; Hutton WC
    Spine (Phila Pa 1976); 1999 Feb; 24(4):320-7. PubMed ID: 10065514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.